Home > Insider Trading > Filing (0001127602-24-005449)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1900910	S Prem Shah	One Cvs Drive Woonsocket RI 02895	Evp And Pres-Pharm, Consumer W	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-02-16	29,473	$76.95	39,765	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership
Common Stock (Restricted)	29,649	Direct
Esop Common Stock	4,789	Direct
Stock Unit (Deferred)	3,350	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Phantom Stock Credits	$1.00			33,755	33,755	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	846	846	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	9,469	9,469	Direct
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	28,596	28,596	Direct
Common Stock	Stock Option	$75.24	2021-08-31	2028-08-31	26,580	26,580	Direct
Common Stock	Stock Option	$74.30	2022-04-01	2031-04-01	28,723	28,723	Direct
Common Stock	Stock Option	$101.09	2023-04-01	2032-04-01	41,580	41,580	Direct
Common Stock	Stock Option	$74.31	2024-04-01	2033-04-01	89,073	89,073	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	33,755	33,755	Direct
2025-04-01	846	846	Direct
2029-04-01	9,469	9,469	Direct
2030-04-01	28,596	28,596	Direct
2028-08-31	26,580	26,580	Direct
2031-04-01	28,723	28,723	Direct
2032-04-01	41,580	41,580	Direct
2033-04-01	89,073	89,073	Direct

Footnotes

Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between 76.93 to 76.99 per share.
Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
Option became exercisable in three equal installments, commencing on 8/31/2021.
Option became exercisable in three equal installments commencing 04/01/2022.
Option became exercisable in four equal installments, commencing 4/1/2023.
Option becomes exercisable in four equal annual installments, commencing 4/1/2024.